Booster Strategies After Janssen Shot Increased Protection Against Omicron
Vaccination with one Janssen dose plus mRNA booster provides higher protection than two Janssen doses.
COVID19 Vaccine
BNT162b2 Prevents Critical COVID-19 in Children and Adolescents
During omicron-predominant period, effectiveness of two doses against hospitalization 68 percent for children, 40 percent for adolescents.
NCCN: Most Cancer Patients Should Receive 5 Doses of an mRNA COVID-19 Vaccine
Most cancer patients should receive 3 primary doses of an mRNA COVID-19 vaccine and 2 booster doses, according to NCCN.
COVID-19 Vaccination Not Linked to Peripartum Adverse Outcomes
Large population-based cohort of more than 22,000 women shows no increased risks with vaccination during pregnancy.
Vaccine-Induced Responses to Omicron, Delta Impaired in Non-Hodgkin Lymphoma Patients
Of the NHL patients with neutralizing antibodies against the WA1/2020 SARS-CoV-2 strain, 70% had antibodies against the delta variant, and 33% had antibodies against the omicron variant.
SARS-CoV-2 Vaccination Seems Safe After MIS-C
No major adverse events seen among 15 children with MIS-C who were subsequently vaccinated against SARS-CoV-2.
CDC: Vaccinated More Likely to Die During Omicron Wave If They Got J&J Shot
However, breakthrough infections among J&J vaccine recipients were similar or lower compared to the other vaccines.
CDC Supports Second COVID-19 Booster for Americans 50 Years and Older
Echoing the FDA, the CDC also supported a second booster for ‘certain immune-compromised individuals’.
COVID-19 Vaccination Early in Pregnancy Not Linked to Fetal Anomalies
Vaccination within teratogenic window not linked to presence of congenital anomalies identified on ultrasonography.
Fourth mRNA COVID-19 Vaccine Immunogenic, Safe
Vaccine efficacy 30 percent for BNT162b2 and 11 percent for mRNA-1273 against any SARS-CoV-2 infection.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...